COLL vs JD · P/E 17, rev $181.9M vs P/E 7.6, rev $187.20B
Collegium Pharmaceutical Inc (COLL) versus JD.com Inc Adr (JD) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
JD.com Inc Adr (JD) is a internet retail company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported JD revenue for 2025-12-31 was $187.20B. Net income was $3.31B. Revenue was up 17.9% from 2024-12-31 to 2025-12-31. JD currently screens at market cap $45.56B and trailing P/E 7.6.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. JD currently screens at market cap $45.56B and trailing P/E 7.6.
Not investment advice. Open the COLL and JD stock pages for the full models.
Not investment advice.